×
About 3,910 results

ALLMedicine Actinic Keratosis Center

Research & Reviews  1,765 results

Histopathological predictor of the progression from actinic keratosis to squamous cell ...
https://doi.org/10.1111/jdv.16680
Journal of the European Academy of Dermatology and Venereology : JEADV; Lee DY, Kim BR et. al.

May 26th, 2020 - The current histopathological classifications for actinic keratosis (AK) are subjective and histopathological factors predicting the progression into invasive squamous cell carcinoma (SCC) remain unclear. To quantitatively assess the histopatholog...

Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonst...
https://doi.org/10.1038/s41379-020-0571-7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc; Lazo de la Vega L, Bick N et. al.

May 26th, 2020 - Although squamous cell carcinomas (SCC) are the most frequent human solid tumor at many anatomic sites, the driving molecular alterations underlying their progression from precursor lesions are poorly understood, especially in the context of photo...

Identification of differentially expressed genes in actinic keratosis samples treated w...
https://doi.org/10.1371/journal.pone.0232146
PloS One; Segura S, Gadea A et. al.

May 15th, 2020 - Actinic keratosis is a common skin disease that may progress to invasive squamous cell carcinoma if left untreated. Ingenol mebutate has demonstrated efficacy in field treatment of actinic keratosis. However, molecular mechanisms on ingenol mebuta...

Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transpla...
https://doi.org/10.1016/j.jaad.2020.04.160
Journal of the American Academy of Dermatology; Tee LY, Sultana R et. al.

May 10th, 2020 - Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.|2020|Tee LY,Sultana R,Tam SYC,Oh CC,|

Developing a risk prediction model for keratinocyte carcinoma in patients with actinic ...
https://doi.org/10.1111/bjd.18966
The British Journal of Dermatology References; Kim Y, Jorgenson E et. al.

May 9th, 2020 - Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.|2020|Kim Y,Jorgenson E,Asgari MM,|

see more →

Guidelines  11 results

Randomized Trial of Four Treatment Approaches for Actinic Keratosis
https://www.nejm.org/doi/full/10.1056/NEJMoa1811850
The New England Journal of Medicine; Jansen,M.,et al

Mar 6th, 2019 - Actinic keratosis is the most frequent premalignant skin disease in the white population. In current guidelines, no clear recommendations are made about which treatment is preferred. METHODS We investigated the effectiveness of four frequently us...

Management of actinic keratosis at specific body sites in patients at high risk of carc...
https://doi.org/10.1111/jdv.14753
Journal of the European Academy of Dermatology and Venereology : JEADV; Richard MA, Amici JM et. al.

Dec 13th, 2017 - Actinic keratoses (AK) arise on sun-exposed regions of the skin. If left untreated, AK may progress to invasive squamous cell carcinoma (SCC), although the rate of progression is low. A practical treatment algorithm for the treatment of AK in stan...

British Association of Dermatologists' guidelines for the care of patients with actinic...
https://doi.org/10.1111/bjd.15107
The British Journal of Dermatology; de Berker D, McGregor JM et. al.

Jan 17th, 2017 - British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.|2017|de Berker D,McGregor JM,Mohd Mustapa MF,Exton LS,Hughes BR,|methods,methods,therapeutic use,therapeutic use,diagnosis,prevention & control...

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - ...
https://doi.org/10.1111/jdv.13180
Journal of the European Academy of Dermatology and Venereology : JEADV; Werner RN, Stockfleth E et. al.

Sep 15th, 2015 - Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing. The goal of these evidence- and consensus-based gui...

Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treat...
https://doi.org/10.1111/jdv.13179
Journal of the European Academy of Dermatology and Venereology : JEADV; Werner RN, Jacobs A et. al.

Sep 9th, 2015 - Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.|2015|Werner RN,Jacobs A,Rosumeck...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  1,891 results

Histopathological predictor of the progression from actinic keratosis to squamous cell ...
https://doi.org/10.1111/jdv.16680
Journal of the European Academy of Dermatology and Venereology : JEADV; Lee DY, Kim BR et. al.

May 26th, 2020 - The current histopathological classifications for actinic keratosis (AK) are subjective and histopathological factors predicting the progression into invasive squamous cell carcinoma (SCC) remain unclear. To quantitatively assess the histopatholog...

Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonst...
https://doi.org/10.1038/s41379-020-0571-7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc; Lazo de la Vega L, Bick N et. al.

May 26th, 2020 - Although squamous cell carcinomas (SCC) are the most frequent human solid tumor at many anatomic sites, the driving molecular alterations underlying their progression from precursor lesions are poorly understood, especially in the context of photo...

Identification of differentially expressed genes in actinic keratosis samples treated w...
https://doi.org/10.1371/journal.pone.0232146
PloS One; Segura S, Gadea A et. al.

May 15th, 2020 - Actinic keratosis is a common skin disease that may progress to invasive squamous cell carcinoma if left untreated. Ingenol mebutate has demonstrated efficacy in field treatment of actinic keratosis. However, molecular mechanisms on ingenol mebuta...

Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transpla...
https://doi.org/10.1016/j.jaad.2020.04.160
Journal of the American Academy of Dermatology; Tee LY, Sultana R et. al.

May 10th, 2020 - Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.|2020|Tee LY,Sultana R,Tam SYC,Oh CC,|

Developing a risk prediction model for keratinocyte carcinoma in patients with actinic ...
https://doi.org/10.1111/bjd.18966
The British Journal of Dermatology References; Kim Y, Jorgenson E et. al.

May 9th, 2020 - Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.|2020|Kim Y,Jorgenson E,Asgari MM,|

see more →

News  223 results

EU Panel Review Supports Decision to Pull Picato From Market
https://www.medscape.com/viewarticle/928957

Apr 19th, 2020 - The European Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its safety review of ingenol mebutate (Picato), finding that the risks for skin cancer from the topical gel used to treat actinic keratosis ou...

Short-course calcipotriol plus 5-FU for AKs: potential major public health impact
https://www.mdedge.com/dermatology/article/218564/actinic-keratosis/short-course-calcipotriol-plus-5-fu-aks-potential-major?channel=245
Bruce Jancin

Mar 6th, 2020 - LAHAINA, HAWAII – The most intriguing recent development in the treatment of actinic keratosis is a study in which a short-course of topical field therapy with calcipotriol plus 5-fluorouracil was shown to create a population of persistent epiderm.

MHRA Suspends Licence for Ingenol Mebutate Gel (Picato)
https://www.medscape.com/viewarticle/925866

Feb 27th, 2020 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update, urging health professionals to stop prescribing ingenol mebutate (Picato, Leo Laboratories) for actinic keratosis and consider other alternatives as ap...

The Week That Wasn't: Virus Cream, Commute Chemicals, Tracing Mumps
https://www.medscape.com/viewarticle/925298

Feb 13th, 2020 - You may have recently seen articles about a skin cream that could protect against infection from mosquito-borne viruses, commutes exposing drivers to harmful chemicals in car seats, and how researchers used gene sequencing to link seemingly separa...

European marketing of Picato suspended while skin cancer risk reviewed
https://www.mdedge.com/clinicianreviews/article/215770/actinic-keratosis/european-marketing-picato-suspended-while-skin?channel=263
Jake Remaly

Jan 17th, 2020 - As a precaution, the European Medicines Agency (EMA) has recommended that patients stop using ingenol mebutate (Picato) while the agency continues to review the safety of the topical treatment, which is indicated for the treatment of actinic kerat.

see more →

Patient Education  11 results see all →